Technical Analysis for NK - NantKwest, Inc.

Grade Last Price % Change Price Change
grade C 5.75 -3.52% -0.21
NK closed down 3.52 percent on Friday, February 21, 2020, on 52 percent of normal volume.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Strong Up Up Down
Historical NK trend table...

Date Alert Name Type % Chg
Lower Bollinger Band Walk Weakness 0.00%
Below Lower BB Weakness 0.00%
Lower Bollinger Band Touch Weakness 0.00%
Lower Bollinger Band Walk Weakness -3.52%
Lower Bollinger Band Touch Weakness -3.52%
1,2,3 Pullback Bullish Bullish Swing Setup -5.27%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup -5.27%
Inside Day Range Contraction -5.27%
Lower Bollinger Band Touch Weakness -5.27%
1,2,3 Pullback Bullish Bullish Swing Setup -3.20%

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile

NantKwest, Inc., a biotechnology company, develops immunotherapeutic agents for various clinical conditions. It is initiating a Phase II clinical trial for its activated natural killer product candidate for the treatment of virally-induced cancers, such as polyomavirus induced Merkel cell carcinoma, human Papillomavirus, induced cervical cancer, and head and neck cancer, as well as infectious diseases comprising Ebola and other viral, fungal, and bacterial infections. The company also holds right to commercialize a range of genetically modified derivatives that kills cancer and virally infected cells. In addition, it focuses on to initiate a Phase I/II clinical trials for target activated natural killer product candidate for acute myeloid leukemia and bulky hematological cancers. The company was formerly known as Conkwest, Inc. and changed its name to NantKwest, Inc. in July 2015. NantKwest, Inc. was founded in 2002 and is headquartered in Cardiff-by-the-Sea, California.
Biotechnology Cancer Infectious Diseases Acute Myeloid Leukemia Infectious Causes Of Cancer Bacterial Infections Head And Neck Cancer Virus Human Papillomavirus Infection Carcinogenesis Cervical Cancer Ebola Merkel Cell Carcinoma Papillomavirus

Is NK a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 9.9
52 Week Low 0.95
Average Volume 2,528,895
200-Day Moving Average 2.17
50-Day Moving Average 5.09
20-Day Moving Average 6.40
10-Day Moving Average 6.25
Average True Range 0.70
ADX 45.1
+DI 22.33
-DI 17.14
Chandelier Exit (Long, 3 ATRs ) 5.56
Chandelier Exit (Short, 3 ATRs ) 7.65
Upper Bollinger Band 6.98
Lower Bollinger Band 5.81
Percent B (%b) -0.05
BandWidth 18.36
MACD Line 0.21
MACD Signal Line 0.42
MACD Histogram -0.2064
Fundamentals Value
Market Cap 456.78 Million
Num Shares 79.4 Million
EPS -1.29
Price-to-Earnings (P/E) Ratio -4.46
Price-to-Sales 7227.62
Price-to-Book 1.46
PEG Ratio 2.18
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 6.35
Resistance 3 (R3) 6.36 6.17 6.25
Resistance 2 (R2) 6.17 6.02 6.17 6.22
Resistance 1 (R1) 5.96 5.92 5.87 5.95 6.18
Pivot Point 5.77 5.77 5.72 5.77 5.77
Support 1 (S1) 5.56 5.62 5.47 5.55 5.32
Support 2 (S2) 5.37 5.52 5.37 5.28
Support 3 (S3) 5.16 5.37 5.25
Support 4 (S4) 5.15